Christopher Ruud, MD
Basic profileMedical Oncology
Christopher Ruud is an Oncology physician. OpenAlex indexes 11 publications with 304 citations (h-index 2).
Overview
Scholarship
indexed output and impact (OpenAlex)Publications indexed by OpenAlex. Counts exclude supporting files.
Citations across these publications.
H-index from these publications.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Phase II results of tasisulam-sodium in previously treated patients with metastatic breast cancer.
Journal of Clinical Oncology
2012 - Time of disease control (TDC) with hormone and chemotherapy in metastatic breast cancer (MBC).
Journal of Clinical Oncology
2012
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
Carl June, MD
University of Pennsylvania
Stuart Orkin, MD
Harvard Medical School
Rainer Storb
University of Washington
Christina Fitzmaurice, MD
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet. Reviewed account links and congress post links can appear separately. Absence of a section means “not yet looked,” never “none found.”